USCOM Ltd (ASX: UCM) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


USCOM Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $7.81 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 190.53 million
Earnings per share -0.015
Dividend per share N/A
Year To Date Return -8.89%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

  • USCOM Ltd (ASX: UCM)
    Latest News

    Two men react in shock at Evolution share price drop record profit
    Healthcare Shares

    The Uscom (ASX:UCM) share price plunged 6% today. Here's why

    The Uscom share price tumbled today after the company released its quarterly cash report, showing falls across every major category.

    Read more »

    a woman
    Share Gainers

    These ASX shares are fighting the spread of coronavirus

    Some ASX shares are fighting coronavirus with demand for their products accelerating along with the spread of the virus. We…

    Read more »

    a woman
    Share Gainers

    Why this small-cap ASX healthcare share surged 39% higher today

    The Uscom Ltd (ASX:UCM) share price surged 29% today after the Chinese government recommended one of its products for use…

    Read more »

    UCM ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About USCOM Ltd

    USCOM Ltd is engaged in the development, design, manufacture, and marketing of premium non-invasive cardiovascular and pulmonary medical devices. The company's geographical segment includes Australia, Asia, America, Europe, and Other regions. It generates maximum revenue from Australia. The company offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, SPIROSONIC, a pulmonary function testing device based on multi-path ultrasound technology and the VENTITEST and VENTITEST-S ultrasonic ventilator calibration devices for optimizing respiratory device performance.

    UCM Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    27 Nov 2023 $0.04 $0.00 0.00% 46,464 $0.04 $0.04 $0.04
    23 Nov 2023 $0.04 $0.00 0.00% 23,780 $0.04 $0.04 $0.04

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    26 Oct 2023 Robert Phillips Issued 4,756,891 $233,087
    Issue of securities. 4,756,891 performance rights
    07 Jul 2023 Robert Phillips Buy 3,164,557 $148,734
    Conversion of securities. As per announcement on 07-07-2022
    There is no transaction reported for conversion of rights.
    12 Apr 2023 Robert Phillips Buy 569,302 $25,618
    Off-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Brett Thomas Crowley Company SecretaryNon Executive director May 2016
    Mr Crowley is a former Partner of Ernst & Young in Hong Kong and Australia, and of KPMG in Hong Kong, and has worked in China establishing and managing JV companies there. Mr Crowley is a chairman, finance director and company secretary of ASX-listed companies and is a former Senior Legal Member of the NSW Civil and Administrative Tribunal.
    Mr Robert Allan Phillips Chief Executive OfficerExecutive ChairmanExecutive Director Nov 2011
    Mr Phillips has 20 years of experience in corporate management since taking Uscom public in 2003 and has taken the company global with regional headquarters in Singapore, Beijing and Budapest with offices in Delawere.
    Mr Christian R Bernecker Non-Executive Director Nov 2011
    Mr Bernecker has more than 10 years of investment experience across capital raising, acquisitions and divestments.
    Mr Xianhui Meng Non-Executive Director Dec 2019
    Mr Meng is an international value investor. Mr Meng has 10 years of experience as a China government departmental head, and 20 years of experience as the Executive Manager and Executive Director of a HK Listed Chinese Pharma specializing in sales and distribution. Mr Meng brings both his international corporate management and strategic skills to the Uscom Board.
    Nick Schicht General Manager

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Mr Robert Allan Phillips 46,664,635 24.49%
    Citicorp Nominees Pty Limited 42,985,397 22.56%
    Jetan Pty Ltd 13,637,064 7.16%
    HSBC Custody Nominees (Australia) Limited 8,539,336 4.48%
    Jetan Pty Ltd <G R Plummer Super Fund A/C> 6,500,000 3.41%
    Invia Custodian Pty Limited <Bozwald Pty Ltd A/C> 3,289,168 1.73%
    Mr David Leroy Boyles 3,000,000 1.58%
    Ms Pamela Jack 2,845,212 1.49%
    Invia Custodian Pty Limited <Riverbel Family No 3 A/C> 2,714,554 1.42%
    Mr Dongjun Sun 2,414,125 1.27%
    Mr Douglas James Cameron 2,375,099 1.25%
    Mrs Christine Quye 2,311,227 1.21%
    Mr Rutherford James Browne & Mrs Sheba Elizabeth Marjorie Browne 2,121,991 1.11%
    Mr Perry Julian Rosenzweig 1,820,711 0.96%
    Mr Christopher James Were & Lockhart Trustee Services No 17 Limited 1,424,095 0.75%
    Trentham Super Pty Ltd <Trentham Sf A/C> 1,351,000 0.71%
    Mr Dean Leon Burrows & Mrs Kerry Ann Burrows 1,100,000 0.58%
    Mak Planning And Design Pty Ltd <S Alston Superannuation A/C> 1,087,001 0.57%
    Nintieth Y Pty Ltd <I K Caldwell & Co Staff A/C> 1,075,000 0.56%
    Pither Investments Pty Ltd <Pither Investments A/C> 1,075,000 0.56%